English  |  正體中文  |  简体中文  |  总笔数 :0  
造访人次 :  52300589    在线人数 :  1157
教育部委托研究计画      计画执行:国立台湾大学图书馆
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
关于TAIR

浏览

消息

著作权

相关连结

跳至: [ 中文 ] [ 数字0-9 ] [ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ]
请输入前几个字:   

显示项目 244846-244855 / 2348487 (共234849页)
<< < 24480 24481 24482 24483 24484 24485 24486 24487 24488 24489 > >>
每页显示[10|25|50]项目

机构 日期 题名 作者
國立臺灣大學 2015 Cetuximab Might Be Detrimental to Metastatic Colorectal Cancer Patients with KRAS Codon 12 Mutations Liang, Yi-Hsin; Lin, Yu-Lin; Liau, Jau-Yu; Tsai, Jia-Huei; Liang, Jin-Tung; Lin, Been-Ren; Hung, Ji-Shiang; Tseng, Li-Hui; Lin, Liang-In; Chang, Yih-Leong; Cheng, Ann-Lii; Yeh, Kun-Huei; 梁逸歆; 林亮音; 曾麗慧; 張逸良; 林育麟; 鄭安理; 葉坤輝; 蔡佳惠; 洪基翔; 林本仁; 廖肇裕; 梁金銅
臺大學術典藏 2020-03-06T05:26:12Z Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations Liang Y.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Tseng L.-H.; Lin L.-I.; YIH-LEONG CHANG; Cheng A.-L.; Yeh K.-H.
臺大學術典藏 2022-03-10T07:58:41Z Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations Liang Y.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Hung J.-S.; LI-HUI TSENG; Lin L.-I.; Chang Y.-L.; Cheng A.-L.; Yeh K.-H.
臺北醫學大學 2006 Cetuximab plus chemotherapy as salvage treatment for advanced colorectal cancer in Taiwanese: Experiences in Taipei Medical University Hospital 戴承正; Cheng-Jeng Tai; Chih-Hsiung Wu; Ching-Shyang Chen; Min-Ter Huang; Jeng-Feng Chiou; Chen-Jei Tai
臺北醫學大學 2006 Cetuximab plus chemotherapy as salvage treatment for advanced colorectal cancer in Taiwanese:Experiences in Taipei Medical University Hospital 吳志雄; 黃銘德; Tai CJ; Wu CH; Chen CS; Huang MT; Chiou JF; Tai CJ;
臺北醫學大學 2006 Cetuximab plus chemotherapy as salvage treatment for advanced colorectal cancer in Taiwanese;Experiences in Taipei Medical University Hospital 邱仲峰; C; J; Tai; C; H; Wu; C; S; Chen; M; T; Huang; J; F; Chiou; C; J; Tai
國立成功大學 2024--JAN Cetuximab Treatment beyond Progression in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Nationwide Population-Based Study (THNS-2021-08) Wang;Hung-Ming;Lou;Pei-Jen;Yang;Muh-Hwa;Chen;Tein-Hua;Lien;Ming-Yu;Lin;Jin-Ching;Chen;Jo-Pai;Lu;Wei-Chen;Lu;Hsueh-Ju;Huang;Tai-Lin;Yen;Chia-Jui;Wu;Shang-Yin;Wang;Hui-Ching;Hsieh;Meng-Che
高雄醫學大學 2007 Cetuximab合併化學治療於轉移性結直腸癌:表皮生長因子受器表現的角色  王照元 
中山醫學大學 2021 Cetyltrimethylammonium Bromide Attenuates the Mesenchymal Characteristics of Hypopharyngeal Squamous Cell Carcinoma Through Inhibiting the EGFR/PI3K/AKT Signaling Pathway Wu, TK; Ou, YC; Chen, YP; Huang, FM; Pan, YR; Lee, CJ
中山醫學大學 2021 Cetyltrimethylammonium Bromide Disrupts Mesenchymal Characteristics of Human Tongue Squamous Cell Carcinoma SCC4 Cells Through Modulating Canonical TGF-beta/Smad/miR-181b/TIMP3 Signaling Pathway Yue, CH; Chen, CH; Pan, YR; Chen, YP; Huang, FM; Lee, CJ

显示项目 244846-244855 / 2348487 (共234849页)
<< < 24480 24481 24482 24483 24484 24485 24486 24487 24488 24489 > >>
每页显示[10|25|50]项目